Table 1.
Age (years) | 53 (range: 26–86) | |
---|---|---|
Sex | ||
male | 135 (91%) | |
female | 13 (9%) | |
Pathological T status | ||
T1 | 42 (29%) | |
T2 | 48 (32%) | |
T3 | 12 (8%) | |
T4a | 41 (28%) | |
T4b | 5 (3%) | |
Pathological N status | ||
N0 | 79 (54%) | |
N1 | 24 (16%) | |
N2 | 42 (28%) | |
N3 | 3 (2%) | |
Pathological 8th AJCC Stage | ||
I | 31 (21%) | |
II | 29 (20%) | |
III | 23 (15%) | |
IVA | 58 (39%) | |
IVB | 7 (5%) | |
Histologic grade | ||
1 | 84 (57%) | |
2 | 59 (40%) | |
3 | 5 (3%) | |
UTX expression | ||
Overexpression | 64 (43%) | |
Low expression | 84 (57%) | |
Vascular invasion | ||
Absent | 124 (84%) | |
Present | 24 (16%) | |
Perineural invasion | ||
Absent | 81 (55%) | |
Present | 67 (45%) | |
Extracapsular extension | ||
Absent | 111 (75%) | |
Present | 37 (25%) | |
Surgical margin | ||
Negative | 137 (93%) | |
Positive | 11 (7%) | |
Smoking | ||
Absent | 26 (18%) | |
Present | 122 (82%) | |
Alcohol | ||
Absent | 30 (20%) | |
Present | 118 (80%) | |
Betel-nut chewing | ||
Absent | 36 (24%) | |
Present | 112 (76%) |
AJCC, American Joint Committee on Cancer